Advertisement

Sentinel Lymph Node Biopsy in the Treatment of Cancer

  • Walter D. HolderJr.
  • Richard L. WhiteJr.

Abstract

Lymph node metastases represent the single most important prognostic indicator in most solid tumors. In general, prognosis is directly related to the number of nodes involved, particularly in patients with melanoma,1 breast,2,3 and colorectal4 carcinomas.5 This basic concept has resulted in the use of regional node dissection for both staging and cure.

Keywords

Breast Cancer Sentinel Lymph Node Sentinel Lymph Node Biopsy Node Biopsy Merkel Cell Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Balch CM, Soong SJ, Murad TM, Ingalls AL, Maddox WA. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg 1981; 193: 377–388.PubMedCrossRefGoogle Scholar
  2. 2.
    Velanovich V, Szymanski W. Lymph node metastasis in breast cancer: common prognostic markers lack predictive value. Ann Surg Oncol 1998; 5: 613–619.PubMedCrossRefGoogle Scholar
  3. 3.
    Anonymous. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. International (Ludwig) Breast Cancer Study Group [see comments]. Lancet 1990; 335: 1565–1568.Google Scholar
  4. 4.
    Chapuis PH, Dent OF, Fisher R, et al. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 1985; 72: 698–702.PubMedCrossRefGoogle Scholar
  5. 5.
    Newland RC, Chapuis PH, Pheils MT, MacPherson JG. The relationship of survival to staging and grading of colorectal carcinoma: a prospective study of 503 cases. Cancer 1981; 47: 1424–1429.PubMedCrossRefGoogle Scholar
  6. 6.
    Eberbach MA, Wahl RL, Argenta LC, Froelich J, Niederhuber JE. Utility of lymphoscintigraphy in directing surgical therapy for melanomas of the head, neck, and upper thorax. Surgery 1987; 102: 433–442.PubMedGoogle Scholar
  7. 7.
    Sugarbaker EV, McBride CM. Melanoma of the trunk: the results of surgical excision and anatomic guidelines for predicting nodal metastasis. Surgery 1976; 80: 22–30.PubMedGoogle Scholar
  8. 8.
    Haagansen CD, Feind CR, Herter FP. Lymphatics of the trunk. In: Haagansen CD, ed. The Lymphatics in Cancer. Philadelphia: WB Saunders, 1972: 437–458.Google Scholar
  9. 9.
    Sappey MPC. Anatomie, Physiologie, Pathologie des Vaisseaux Lymphatiques Consideres Chez l’Homme et les Vertebres. Paris: A. DeLahaye and E. Lecrosnier, 1974.Google Scholar
  10. 10.
    Uren RF, Howman-Giles RB, Shaw HM, Thompson JF, McCarthy WH. Lymphoscintigraphy in high-risk melanoma of the trunk: predicting draining node groups, defining lymphatic channels and locating the sentinel node. J Nucl Med 1993; 34: 1435–1440.PubMedGoogle Scholar
  11. 11.
    Kapteijn BA, Nieweg 0E, Liem I, et al. Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dye. Ann Surg Oncol 1997; 4: 156–160.PubMedCrossRefGoogle Scholar
  12. 12.
    Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 39 2399.Google Scholar
  13. 13.
    Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977; 39: 456–466.PubMedCrossRefGoogle Scholar
  14. 14.
    Wong JH, Cagle LA, Morton DL. Lymphatic drainage of skin to a sentinel lymph node in a feline model. Ann Surg 1991; 214: 637–641.PubMedCrossRefGoogle Scholar
  15. 15.
    Johnson LW, Sehon J, Li BD. Potential utility of sentinel node biopsy in the original surgical assessment of Hurthle cell tumors of the thyroid: 23-year institutional review of Hurthle cell neoplasms. J Surg Oncol 1999; 70: 100–102.PubMedCrossRefGoogle Scholar
  16. 16.
    Kelemen PR, Van Herle AJ, Giuliano AE. Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg 1998; 133: 288–292.PubMedCrossRefGoogle Scholar
  17. 17.
    Little AG, DeHoyos A, Kirgan DM, Arcomano TR, Murray KD. Intraoperative lymphatic mapping for non-small cell lung cancer: the sentinel node technique. J Thorac Cardiovasc Surg 1999; 117: 220–234.PubMedCrossRefGoogle Scholar
  18. 18.
    Pitman KT, Johnson JT, Edington H, et al. Lymphatic mapping with isosulfan blue dye in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1998; 124: 790–793.PubMedGoogle Scholar
  19. 19.
    Mamelle G, Pampurik J, Luboinski B, Lancar R, Lusinchi A, Bosq J. Lymph node prognostic factors in head and neck squamous cell carcinomas. Am J Surg 1994; 168: 494–498.PubMedCrossRefGoogle Scholar
  20. 20.
    Echt ML, Finan MA, Hoffman MS, Kline RC, Roberts WS, Fiorica JV. Detection of sentinel lymph nodes with lymphazurin in cervical, uterine, and vulvar malignancies. South Med J 1999; 92: 204–208.PubMedCrossRefGoogle Scholar
  21. 21.
    de Hullu JA, Doting E, Piers DA, et al. Sentinel lymph node identification with technetium-99mlabeled nanocolloid in squamous cell cancer of the vulva. J Nucl Med 1998; 39: 1381–1385.PubMedGoogle Scholar
  22. 22.
    Levenback C, Burke TW, Morris M, Malpica A, Lucas KR, Gershenson DM. Potential applications of intraoperative lymphatic mapping in vulvar cancer. Gynecol Oncol 1995; 59: 216–220.PubMedCrossRefGoogle Scholar
  23. 23.
    Senthil KM, Ananthakrishnan N, Prema V. Predicting regional lymph node metastasis in carcinoma of the penis: a comparison between fine-needle aspiration cytology, sentinel lymph node biopsy and medial inguinal lymph node biopsy. Br J Urol 1998; 81: 453–457.CrossRefGoogle Scholar
  24. 24.
    Messina JL, Reintgen DS, Cruse CW, et al. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol 1997; 4: 389–395.PubMedCrossRefGoogle Scholar
  25. 25.
    Hill AD, Brady MS, Coit DG. Intraoperative lymphatic mapping and sentinel lymph node biopsy for Merkel cell carcinoma. Br J Surg 1999; 86: 518–521.PubMedCrossRefGoogle Scholar
  26. 26.
    Ames SE, Krag DN, Brady MS. Radiolocalization of the sentinel lymph node in Merkel cell carcinoma: a clinical analysis of seven cases. J Surg Oncol 1998; 67: 251–254.PubMedCrossRefGoogle Scholar
  27. 27.
    Starz H, Balda BR, Bachter D, Buchels H, Vogt H. Secondary lymph node involvement from primary cutaneous large B-cell lymphoma of the leg: sentinel lymph nodectomy as a new strategy for staging circumscribed cutaneous lymphomas. Cancer 1999; 85: 199–207.PubMedCrossRefGoogle Scholar
  28. 28.
    Joosten JJ, Strobbe LJ, Wauters CA, Pruszczynski M, Wobbes T, Ruers TJ. Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg 1999; 86: 482–486.PubMedCrossRefGoogle Scholar
  29. 29.
    Winchester DJ, Sener SF, Winchester DP, et al. Sentinel lymphadenectomy for breast cancer: experience with 180 consecutive patients: efficacy of filtered technetium 99m sulphur colloid with overnight migration time. J Am Coll Surg 1999; 188: 597–603.PubMedCrossRefGoogle Scholar
  30. 30.
    Linehan DC, Hill AD, Tran KN, et al. Sentinel lymph node biopsy in breast cancer: unfiltered radioisotope is superior to filtered. J Am Coll Surg 1999; 188: 377–381.PubMedCrossRefGoogle Scholar
  31. 31.
    Tafra L, Chua AN, Ng PC, Aycock D, Swanson M, Lannin D. Filtered versus unfiltered technetium sulfur colloid in lymphatic mapping: a significant variable in a pig model [see comments]. Ann Surg Oncol 1999; 6: 83–87.PubMedCrossRefGoogle Scholar
  32. 32.
    Bartolomei M, Testori A, Chinol M, et al. Sentinel node localization in cutaneous melanoma: lymphoscintigraphy with colloids and antibody fragments versus blue dye mapping. Eur J Nucl Med 1998; 25: 1489–1494.PubMedCrossRefGoogle Scholar
  33. 33.
    Ratanawichitrasin A, Levy L, Myles J, Crowe JP. Experience with lymphatic mapping in breast cancer using isosulfan blue dye. J Women’s Health 1998; 7: 873–877.PubMedCrossRefGoogle Scholar
  34. 34.
    Thomson W, MacKie RM. Comparison of five antimelanoma antibodies for identification of melanocytic cells on tissue sections in routine dermatopathology. J Am Acad Dermatol 1989; 21: 1280–1284.PubMedCrossRefGoogle Scholar
  35. 35.
    Czerniecki BJ, Scheff AM, Callans LS, et al. Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer 1999; 85: 1098–1103.PubMedCrossRefGoogle Scholar
  36. 36.
    Pendas S, Dauway E, Cox C, et al. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Am Surg 1999; 65: 500–505.PubMedGoogle Scholar
  37. 37.
    Schreiber RH, Pendas S, Ku NN, et al. Micro-staging of breast cancer patients using cytokeratin staining of the sentinel lymph node [see comments]. Ann Surg Oncol 1999; 6: 95–101.PubMedCrossRefGoogle Scholar
  38. 38.
    Wang X, Heller R, VanVoorhis N, et al. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 1994; 220: 768–774.PubMedCrossRefGoogle Scholar
  39. 39.
    Bieligk SC, Ghossein R, Bhattacharya S, Coit DG. Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes. Ann Surg Oncol 1999; 6: 232–240.PubMedCrossRefGoogle Scholar
  40. 40.
    Goydos JS, Ravikumar TS, Germino FJ, Yudd A, Bancila E. Minimally invasive staging of patients with melanoma: sentinel lymphadenectomy and detection of the melanoma-specific proteins MART-1 and tyrosinase by reverse transcriptase polymerase chain reaction. J Am Coll Surg 1998; 187: 182–188.PubMedCrossRefGoogle Scholar
  41. 41.
    Bostick PJ, Huynh KT, Sarantou T, et al. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple-marker RT-PCR. Int J Cancer 1998; 79: 645–651.PubMedCrossRefGoogle Scholar
  42. 42.
    Balch CM, Soong SJ, Milton GW, et al. A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg 1982; 196: 677–684.PubMedCrossRefGoogle Scholar
  43. 43.
    Veronesi U, Adamus J, Bandiera DC, et al. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med 1977; 297: 627–630.PubMedCrossRefGoogle Scholar
  44. 44.
    Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme [see comments]. Lancet 1998; 351: 793796.Google Scholar
  45. 45.
    Sim FH, Taylor WF, Pritchard DJ, Soule EH. Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. Mayo Clin Proc 1986; 61: 697–705.PubMedCrossRefGoogle Scholar
  46. 46.
    Balch CM, Ross M, Soong SJ, Harrison R. Longterm results of a prospective, randomized trial involving elective regional lymph node dissection in patients with intermediate thickness melanomas. Proc Soc Surg Oncol 1999; abstract.Google Scholar
  47. 47.
    Leong SPL. The role of sentinel lymph nodes in human solid cancer. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer Principles and Practice of Oncology, 5th ed. Cedar Knolls, NJ: Lippincott-Raven, 1998: 1–12.Google Scholar
  48. 48.
    Gershenwald JE, Thompson W, Mansfield PF, et al. Multiinstitutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999; 17: 976–983.PubMedGoogle Scholar
  49. 49.
    Gallery C, Cochran AJ, Roe DJ, et al. Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes. Ann Surg 1982; 196: 69–75.CrossRefGoogle Scholar
  50. 50.
    Bostick P, Essner R, Glass E, et al. Comparison of blue dye and probe-assisted intraoperative lymphatic mapping in melanoma to identify sentinel nodes in 100 lymphatic basins. Arch Surg 1999; 134: 43–49.PubMedCrossRefGoogle Scholar
  51. 51.
    Joseph E, Brobeil A, Glass F, et al. Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes. Ann Surg On-col 1998; 5: 119–125.Google Scholar
  52. 52.
    Heaton KM, Sussman JJ, Gershenwald JE, et al. Surgical margins and prognostic factors in patients with thick (4 mm) primary melanoma. Ann Surg Oncol 1998; 5: 322–328.PubMedCrossRefGoogle Scholar
  53. 53.
    Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989; 63: 18 1187.Google Scholar
  54. 54.
    Andrulis IL, Bull SB, Blackstein ME, et al. neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group. J Clin Oncol 1998; 16: 1340–1349.PubMedGoogle Scholar
  55. 55.
    Fisher ER, Swamidoss S, Lee CH, Rockette H, Redmond C, Fisher B. Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer 1978; 42: 2025–2031.PubMedCrossRefGoogle Scholar
  56. 56.
    Hainsworth PJ, Tjandra JJ, Stillwell RG, et al. Detection and significance of occult metastases in node-negative breastcancer. Br J Surg 1993; 80: 459–463.PubMedCrossRefGoogle Scholar
  57. 57.
    Zavotsky J, Hansen N, Brennan MB, Turner RR, Giuliano AE. Lymph node metastasis from ductal carcinoma in situ with microinvasion. Cancer 71. Belli F, Lenisa L, Clemente C, et al. Sentinel 1999; 85: 2439–2443.Google Scholar
  58. 58.
    Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2: 335–339.PubMedCrossRefGoogle Scholar
  59. 59.
    Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer [see comments]. Ann Surg 1994; 220: 391–398.PubMedCrossRefGoogle Scholar
  60. 60.
    Ferrari M, Cremonesi M, Sacco E, et al. [Radiation protection in the use of tracers in radioguided breast surgery]. Radiol Med (Torino) 1998; 96: 607–611.Google Scholar
  61. 61.
    Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer-a multicenter validation study [see comments]. N Engl J Med1998; 339: 941–946.Google Scholar
  62. 62.
    Giuliano AE, Jones RC, Brennan M, Statman R Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 15: 2345–2350.PubMedGoogle Scholar
  63. 63.
    Reynolds C, Mick R, Donohue JH, et al. Senmetastasis: Can axillary 77. Mraz-Gernhard S dissection be avoided in some patients with breast cancer? J Clin Oncol 1999; 17: 1720 1726 (abstract).Google Scholar
  64. 64.
    Fowler JEJ. Sentinel lymph node biopsy for stag ing penile cancer. Urology 1984; 23: 352–353.PubMedCrossRefGoogle Scholar
  65. 65.
    Cody HS, Hill AD, Tran KN, Brennan MF, Bogen PI. Credentialing for breast lymphatic map ping: how many cases are enough? Ann Surg 1999; 229: 723–726.PubMedCrossRefGoogle Scholar
  66. 66.
    Morton D, Giuliano A, Reintgen D, Roses DF, Ross M, Thompson JE Symposium: lymphatic mapping and sentinel node biopsy in patients with breast cancer and melanoma-part I. Contemp Surg 1998; 53: 281–298.Google Scholar
  67. 67.
    Gershenwald JE, Colome MI, Lee JE, et al. P negative sentinel 80. Reintgen D, Cruse CW, lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998; 16: 2253–2260.PubMedGoogle Scholar
  68. 68.
    Giuliano AE. Mapping a pathway for axillar staging: a personal perspective on the current status of sentinel lymph node dissection for 82. breast cancer. Arch Surg 1999; 134: 195–199.PubMedCrossRefGoogle Scholar
  69. 69.
    Albertini JJ, Cruse CW, Rapaport D, et al. Intra operative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996; 223: 217–224.PubMedCrossRefGoogle Scholar
  70. 70.
    Bachter D, Balda BR, Vogt H, Buchels H. lective cervical lymphadenectomy for early-stage melanomas of the head and neck. J Clin Oncol tinel1998; 37: 1278–282Google Scholar
  71. 71.
    Belli F, Lenisa L, Intraoper ative lymphatic mapping for early-stage mela noma of the head and neck. Am J Surg nodal metastases. 1998; 84: 24–28.Google Scholar
  72. 72.
    Bostick P, Essner R, Sarantou T, et al. Intraoper ative lymphatic mapping for early-stage mela noma of the head and neck. Am J Surg nodal metastases. Tumori 1997; 174: 536–539.CrossRefGoogle Scholar
  73. 73.
    Cafiero F, Peressini A, Gipponi M, et al. Sentinel node biopsy in patients with cutaneous mela noma. Semin Surg Oncol 1998; 15: 284–286.PubMedCrossRefGoogle Scholar
  74. 74.
    Krag DN, Meijer SJ, Weaver DL, et al. Minimal access surgery for staging of malignant melanoma. Arch Surg 1995; 130: 654–658.PubMedCrossRefGoogle Scholar
  75. 75.
    Leong SP, Steinmetz I, Habib FA, et al. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg 1997; 132: 666–672.PubMedCrossRefGoogle Scholar
  76. 76.
    Morton DL, Wen DR, Foshag LJ, Essner R, Coch.ran A. Intraoperative lymphatic mapping and seage melanomas of the head and neck. J Clin Oncol71., Sagebiel RW, Kashani-Sabetlymphadenectomy. Int J Dermatol 1998; 37: 278–282.Google Scholar
  77. 78.
    Pijpers R, Collet GJ, Meijer S, Hoekstra OS. The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanoma. Eur J Nucl Med 1995; 22: 1238 1241.Google Scholar
  78. 79.
    Pijpers R, Borgstein PJ, Meijer S, Hoekstra OS, van Hattum LH, Teule GJ. Sentinel node biopsy in melanoma patients: dynamic lymphoscintig raphy followed by intraoperative gamma probe and vital dye guidance. World J Surg 1997; 21: 788–792.PubMedCrossRefGoogle Scholar
  79. 80.
    Reintgen D, Cruse CW, Wells derly progression of melanoma nodal metastaor II melanoma. J Clin Oncol 1998; 16: 2253–2260Google Scholar
  80. 81.
    Wells KE, Rapaport DP, Cruse CW, et al. Sentinel lymph node biopsy in melanoma of the head and neck. Plast Reconstr Surg 1997; 100: 591–594.PubMedCrossRefGoogle Scholar
  81. 82.
    Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient Ntra with breast cancer [see comments]. JAMA 1996; 276: 1818–1822.PubMedCrossRefGoogle Scholar
  82. 83.
    Barnwell JM, Arredondo MA, Kollmorgen D, et al. Sentinel node biopsy in breast cancer. Ann Surg Oncol 1998; 5: 126–130.PubMedCrossRefGoogle Scholar
  83. 84.
    Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy n breast cancer: guidelines and pitfalls of lym phoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186: 275–283.PubMedCrossRefGoogle Scholar
  84. 85.
    Cox CE, Pendas S, Cox JM, et al. Guidelines for 1998 lymphatic mapping of 93. Pijpers R, Meijer S, Hoekst patients with breast cancer [see comments]. Ann o Surg 1998; 227: 645–651.CrossRefGoogle Scholar
  85. 86.
    Crossin JA, Johnson AC, Stewart PB, Turner WWJ. Gamma-probe-guided resection of the sen 1998; 64: 666–668.Google Scholar
  86. 87.
    Flett MM, Going JJ, Stanton PD, Cooke TG. Sen tinel node localization in patients with breast cancer. Br J Surg 1998; 85: 991–993.PubMedCrossRefGoogle Scholar
  87. 88.
    Guenther JM, Krishnamoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 1997; 3: 336–340.PubMedGoogle Scholar
  88. 89.
    Jaderborg JM, Harrison PB, Kiser JL, Maynard SL. The feasibility and accuracy of the sentinel lymph node biopsy for breast carcinoma. Am Surg 1999; 65: 699–705.PubMedGoogle Scholar
  89. 90.
    Miner TJ, Shriver CD, Jaques DP, Maniscalc Theberge ME, Krag D. Sentinel lymph node biopsy for breast cancer: the role of previous bi 1996, 65, 496–498.Google Scholar
  90. 91.
    Nwariaku FE, Euhus DM, Beitsch PD, et al. Sen tinel lymph node biopsy, an alternative to elec Surg 1998; 176: 529–531.Google Scholar
  91. 92.
    O’Hea BJ, Hill AD, El-Shirbiny AM, et al. Sentnel lymph node biopsy in breast cancer: initial for staging breast cancer. Am J Surg 1998; 176: 423–427Google Scholar
  92. 94.
    Rubio IT, Korourian S, Cowan C, Krag DN, Colert M, Klimberg VS. Sentinel lymph node bi opsy for staging breast cancer. Am J Surg 1998; 176: 532–537.PubMedCrossRefGoogle Scholar
  93. 95.
    Sandrucci S, Mussa A. Sentinel lymph node biopsy and axillary staging of Tl-T2 NO breast can cer: a multicenter study. Semin Surg Oncol 1998; 15: 278–283.PubMedCrossRefGoogle Scholar
  94. 96.
    Snider H, Dowlatshahi K, Fan M, Bridger WM, Rayudu G, Oleske D. Sentinel node biopsy in the staging of breast cancer. Am J Surg 1998; 176: 305–310.PubMedCrossRefGoogle Scholar
  95. 97.
    Veronesi U, Paganelli G, Viale G, et al. Sentinel olymph node biopsy and axillary dissection in reast cancer: results in a large series [see com ments]. J Natl Cancer Inst 1999; 91: 368–373.PubMedCrossRefGoogle Scholar
  96. 98.
    Viale G, Bosari S, Mazzarol G, et al. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer 1999; 85: 2433–2438.PubMedCrossRefGoogle Scholar
  97. 99.
    Thompson JF, McCarthy WH, Bosch CM, et al. Sentitive axillary dissection for breast cancer. Am J nel lymph node status as an indicator of the i presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995; 5: 255–260.Google Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Walter D. HolderJr.
  • Richard L. WhiteJr.

There are no affiliations available

Personalised recommendations